ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea flag South Korea · Delayed Price · Currency is KRW
90,000
-1,800 (-1.96%)
Sep 11, 2026, 3:30 PM KST

ST Pharm Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
53,83430,54663,40550,09750,20139,203
Short-Term Investments
5,492-9,51840,000-44,000
Trading Asset Securities
111,11460,44448,001--10,013
Cash & Short-Term Investments
170,44090,990120,92490,09750,20193,216
Cash Growth
91.23%-24.75%34.22%79.47%-46.15%-33.72%
Accounts Receivable
47,27196,66167,846120,56694,21062,949
Other Receivables
-1,7681,9721,5003,1311,499
Receivables
47,27198,91369,817122,06697,34164,448
Inventory
196,386169,471126,963120,736107,62380,809
Prepaid Expenses
10,3917,7389,12011,9015,8185,039
Other Current Assets
22,6335,5553,2543,5772,251628.76
Total Current Assets
447,121372,668330,078348,378263,234244,142
Property, Plant & Equipment
359,885359,334338,695280,105257,885210,190
Long-Term Investments
4,8848,1128,91310,72811,49213,264
Goodwill
-11,80810,5999,9508,9478,455
Other Intangible Assets
17,2485,1985,9333,5133,5324,164
Long-Term Deferred Tax Assets
14,13716,5027,3527,49817,12715,732
Other Long-Term Assets
4,7598,52220,30515,2648,4362,619
Total Assets
848,034782,567721,876675,436570,652498,565

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
19,55411,79610,64617,66118,09512,865
Accrued Expenses
-11,6564,5668,2649,3656,558
Short-Term Debt
72,76776,53363,88320,878105,854-
Current Portion of Long-Term Debt
--8,3338,3338,29315,000
Current Portion of Leases
1,3451,2531,1581,0391,185587.24
Current Income Taxes Payable
8,5278,5397,1154,4302,3771,322
Current Unearned Revenue
-5,7986,8182,391--
Other Current Liabilities
94,02949,17630,76120,74834,05416,243
Total Current Liabilities
196,222164,752133,28183,745179,22452,575
Long-Term Debt
--43,255159,68916,70791,451
Long-Term Leases
703.02929.221,5122,1432,481479.1
Long-Term Unearned Revenue
-2,5522,7382,791-956.3
Pension & Post-Retirement Benefits
647.82604.52766.09584.87--
Other Long-Term Liabilities
21,39020,72637,33339,57831,13827,071
Total Liabilities
218,963189,563218,885288,530229,549172,533

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
10,43810,35110,0769,4049,4049,404
Additional Paid-In Capital
377,157358,218315,593225,940195,747195,714
Retained Earnings
221,872204,243159,437135,729126,893115,590
Comprehensive Income & Other
20,01020,63118,02513,4765,5872,266
Total Common Equity
629,477593,443503,132384,550337,632322,974
Minority Interest
-405.87-438.89-141.192,3563,4713,058
Shareholders' Equity
629,071593,004502,991386,906341,103326,033
Total Liabilities & Equity
848,034782,567721,876675,436570,652498,565

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
74,81578,714118,142192,082134,521107,517
Net Cash (Debt)
95,62512,2762,782-101,984-84,320-14,301
Net Cash Growth
-341.27%----
Net Cash Per Share
4386.00572.43142.64-5422.17-4483.00-766.21
Filing Date Shares Outstanding
20.8820.720.1518.8118.8118.81
Total Common Shares Outstanding
20.8820.720.1518.8118.8118.81
Working Capital
250,899207,916196,797264,63484,010191,567
Book Value Per Share
30152.2128666.3924965.7720445.2617950.7617171.46
Tangible Book Value
612,229576,437486,600371,088325,153310,355
Tangible Book Value Per Share
29326.0127844.9124145.4419729.5017287.3016500.56
Land
-60,44960,20060,02459,99952,910
Buildings
-204,219149,266146,984118,168102,362
Machinery
-284,708203,768195,642157,855120,141
Construction In Progress
-5,28293,14920,79444,42150,144